• 1391 Citations
  • 5 h-Index
19982016
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marco Lioce is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Radiotherapy Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Radiation Oncology Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Multicenter Studies Medicine & Life Sciences
Chemokine CXCL1 Medicine & Life Sciences
Central Nervous System Medicine & Life Sciences
Epithelioid Hemangioendothelioma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2016

  • 1391 Citations
  • 5 h-Index
  • 11 Article
3 Citations (Scopus)

Waiting time for radiation therapy after breast-conserving surgery in early breast cancer: A retrospective analysis of local relapse and distant metastases in 615 patients

Caponio, R., Ciliberti, M. P., Graziano, G., Necchia, R., Scognamillo, G., Pascali, A., Bonaduce, S., Milella, A., Matichecchia, G., Cristofaro, C., Di Fatta, D., Tamborra, P. & Lioce, M., 2016, In : European Journal of Medical Research. 21, 1, 32.

Research output: Contribution to journalArticle

Segmental Mastectomy
Radiotherapy
Breast Neoplasms
Neoplasm Metastasis
Recurrence
2 Citations (Scopus)
Epithelioid Hemangioendothelioma
Veins
Radiotherapy
Head
Hemangioendothelioma
3 Citations (Scopus)

MRI evaluation of post-mastectomy irradiated breast implants: Prevalence and analysis of complications

Rella, L., Telegrafo, M., Nardone, A., Milella, A., Ianora, A. A. S., Lioce, M., Angelelli, G. & Moschetta, M., Sep 1 2015, In : Clinical Radiology. 70, 9, p. 948-953 6 p.

Research output: Contribution to journalArticle

Breast Implants
Mastectomy
Magnetic Resonance Imaging
Radiotherapy
Seroma
Chemokine CXCL1
Circulating Neoplastic Cells
Transforming Growth Factors
Breast Neoplasms
Ligands
34 Citations (Scopus)

Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity

Porcelli, L., Quatrale, A. E., Mantuano, P., Leo, M. G., Silvestris, N., Rolland, J. F., Carioggia, E., Lioce, M., Paradiso, A. & Azzariti, A., Jun 2013, In : Molecular Oncology. 7, 3, p. 308-322 15 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Pancreatic Neoplasms
gemcitabine
Radiotherapy
Therapeutics